Fig. 3: Prediction of VE based on GD. | Nature Medicine

Fig. 3: Prediction of VE based on GD.

From: Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance

Fig. 3

The VE-GD model was trained using all non-variant-specific VEs, and estimations were made on all (n = 23) variant-specific VEs. a, Estimated and observed VE for variants by vaccine product. Source of the VE data is indexed behind vaccine product names, available in Supplementary Table 5. b, Calibration plot for the prediction outcome in validation data. The predicted VEs are close to the observed VEs with a CCC of 0.95 (95% CI: 0.88–0.98).

Back to article page